Formulation Development and Compatibility Study for BTD (Brimonidine Tartrate, Timolol Maleate, and Dorzolamide HCl) used in the Management of Glaucoma Disease. Asian Journal of Pharmaceutics (AJP), [S. l.], v. 11, n. 03, 2017. DOI: 10.22377/ajp.v11i03.1465. Disponível em: https://www.asiapharmaceutics.info/index.php/ajp/article/view/1465. Acesso em: 14 apr. 2026.